SUMMARY A total of 102 families with Duchenne muscular dystrophy has been studied with linked DNA polymorphisms as an aid to estimating carrier risks for female relatives. Early work using probes RC8, L1.28, and pXUT23 gave very little clinically useful information because of the high recombination rates between these probes and Duchenne muscular dystrophy and the low proportion of women who were heterozygous. Clinically useful results were obtained using probes 754, and particularly pERT87. Examples are given of deductions which can be made using these probes. The importance of a genetic register is stressed as a tool for long term contact with the families and other professionals.
In Manchester, clinical genetic services for Duchenne muscular dystrophy (DMD) are organised through a genetic register. The primary purpose of the register is to counsel all females at risk of being carriers of DMD in the North West Region (population 4 million). The register was set up some years ago, before gene tracking became possible, but in anticipation of such a development. We have aimed at complete ascertainment of all DMD families in the region.
Although there has been continuous development in gene tracking for DMD, we can divide our work into three cycles. First we used Ll.28' and RC8' or pXUT232; RC8 and Ll.28 both show polymorphic bands with Taql and can conveniently be used in a mixed hybridisation. In the second cycle we used 99-63 and 7544 which again can be used in a mixed hybridisation with a PsI digest. The third cycle is based on the pERT87 probes.5
In common with other groups, we felt that attempts at prenatal diagnosis using the earlier generations of probes would not be justified. Carrier risks could be modified in most informative families, but only in a few cases would the change be clinically significant, that is, large enough to persuade a woman at risk to change her mind about fetal sexing. The maximum change achievable with a given Many of the families without obligate carriers are still being worked up. In three cases we have found deletions and in several others a sporadic affected boy has inherited the same pERT allele as two healthy brothers, making it unlikely that his mother is a carrier. These cases are being tested with bridging markers. 
Information systems
We quickly discovered that organising the flow of information between the clinicians and the laboratory was not a trivial task. Organising the workload is much more complex for a laboratory offering a service than for a purely research laboratory. It is highly inefficient to work up one family fully before moving on to another. As far as possible, blood samples are taken at the regular annual review of each family. Samples are best processed in batches of a size to fill a gel. Results from one sample are seldom meaningful until combined with other results from the family. We are dealing with several diseases apart from DMD, and our data files now include over 4000 patients, 2500 DNA samples, and 3000 RFLP results. We have devoted considerable effort to devising a system to handle this data efficiently, robustly, and confidentially. Our system runs on IBM PC-AT microcomputers under dBaseIII. It maintains linked data files of patients and RFLP results and an inventory of DNA samples. We have operated this system for about 18 months without trouble, and have not noticed any degradation of performance as the volume of data rises. Copies of the programmes are available on request.
Discussion
A particular feature of the DMD work in Manchester has been the use of the genetic register. We see this as the natural approach to taking long term responsibility for counselling these families. The register has advantages for the families: they can consider what tests they would want without the pressure of a pregnancy. This is particularly important where family members may first realise they are at risk as a result of contact with the genetic services. Ideally, in advance of any pregnancy, the pedigree will have been worked up, CK levels estimated twice, DNA samples collected, and appropriate females checked to see whether they are informative. Then, prenatal diagnosis need not be attempted if RFLP analysis shows that the mother is unlikely to be a carrier or is uninformative for available probes
The long term contact which follows from the register approach is particularly important with the rapid advances in this field. Our families are aware that all risks are provisional pending further progress. All families are reviewed annually but, increasingly, girls at risk are contacting us to let us know that they are planning marriage or a pregnancy, so that they can be counselled using the latest information available. This arrangement is also helpful to the laboratory for planning priorities. 
